BG105548A - Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors - Google Patents
Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitorsInfo
- Publication number
- BG105548A BG105548A BG105548A BG10554801A BG105548A BG 105548 A BG105548 A BG 105548A BG 105548 A BG105548 A BG 105548A BG 10554801 A BG10554801 A BG 10554801A BG 105548 A BG105548 A BG 105548A
- Authority
- BG
- Bulgaria
- Prior art keywords
- nucleotide synthesis
- formulation
- synthesis inhibitors
- improved therapeutic
- therapeutic range
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19857009A DE19857009A1 (de) | 1998-12-10 | 1998-12-10 | Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren |
| PCT/EP1999/009380 WO2000033876A1 (fr) | 1998-12-10 | 1999-12-01 | Formulation a spectre therapeutique elargi, contenant des inhibiteurs de la synthese des nucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG105548A true BG105548A (en) | 2001-12-29 |
Family
ID=7890633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105548A BG105548A (en) | 1998-12-10 | 2001-05-30 | Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1137438B1 (fr) |
| JP (1) | JP2002531525A (fr) |
| KR (1) | KR20010080729A (fr) |
| CN (1) | CN1189214C (fr) |
| AR (1) | AR021577A1 (fr) |
| AT (1) | ATE218370T1 (fr) |
| AU (1) | AU766810B2 (fr) |
| BG (1) | BG105548A (fr) |
| BR (1) | BR9916006A (fr) |
| CA (1) | CA2354266A1 (fr) |
| CZ (1) | CZ20012029A3 (fr) |
| DE (2) | DE19857009A1 (fr) |
| DK (1) | DK1137438T3 (fr) |
| EA (1) | EA005136B1 (fr) |
| EE (1) | EE200100305A (fr) |
| ES (1) | ES2178496T3 (fr) |
| HK (1) | HK1041598B (fr) |
| HR (1) | HRP20010429A2 (fr) |
| HU (1) | HUP0104624A3 (fr) |
| IL (1) | IL143586A0 (fr) |
| MX (1) | MXPA01005861A (fr) |
| NO (1) | NO20012719D0 (fr) |
| NZ (1) | NZ511882A (fr) |
| PL (1) | PL349336A1 (fr) |
| PT (1) | PT1137438E (fr) |
| SI (1) | SI1137438T1 (fr) |
| SK (1) | SK284842B6 (fr) |
| WO (1) | WO2000033876A1 (fr) |
| YU (1) | YU39901A (fr) |
| ZA (1) | ZA200104815B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10112924A1 (de) * | 2001-03-13 | 2002-10-02 | Erich Eigenbrodt | 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate |
| JP4382354B2 (ja) * | 2001-03-13 | 2009-12-09 | ヴァルブルク・グリコムド・ゲーエムベーハー | １−ブタン酸誘導体およびその使用 |
| GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| US20040127435A1 (en) * | 2002-08-02 | 2004-07-01 | Regents Of The University Of California | Uses for inhibitors of inosine monophosphate dehydrogenase |
| AU2003258454A1 (en) | 2002-09-06 | 2004-04-30 | Schebo®Biotech Ag | Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| JPWO2005060980A1 (ja) * | 2003-12-24 | 2007-12-13 | 正彬 少名子 | 疾患治療用医薬及び糖尿病治療用医薬 |
| DE102005017592A1 (de) * | 2005-04-16 | 2006-10-19 | Lindner, Jürgen, Dr. med. | Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem |
| JP4657384B2 (ja) | 2007-05-03 | 2011-03-23 | ファイザー・リミテッド | ナトリウムチャンネルモジュレーターとしての２−ピリジンカルボキサミド誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4127737A1 (de) * | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
| EP0538783B1 (fr) * | 1991-10-23 | 1995-09-27 | Hoechst Aktiengesellschaft | Dérivés d'amides de l'acide n-phényl-cyano-2-hydroxy-3-crotonique et leur utilisation comme médicaments ayant des propriétés immunomodulants |
| IT1254519B (it) * | 1992-03-16 | 1995-09-25 | Chiesi Farma Spa | Associazioni di composti ad attivita' antivirale |
| DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
| AU4596097A (en) * | 1996-09-26 | 1998-04-17 | Williams, James W. | Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives |
-
1998
- 1998-12-10 DE DE19857009A patent/DE19857009A1/de not_active Withdrawn
-
1999
- 1999-12-01 CA CA002354266A patent/CA2354266A1/fr not_active Abandoned
- 1999-12-01 PT PT99961041T patent/PT1137438E/pt unknown
- 1999-12-01 WO PCT/EP1999/009380 patent/WO2000033876A1/fr not_active Application Discontinuation
- 1999-12-01 EP EP99961041A patent/EP1137438B1/fr not_active Expired - Lifetime
- 1999-12-01 EA EA200100647A patent/EA005136B1/ru not_active IP Right Cessation
- 1999-12-01 DK DK99961041T patent/DK1137438T3/da active
- 1999-12-01 NZ NZ511882A patent/NZ511882A/en unknown
- 1999-12-01 ES ES99961041T patent/ES2178496T3/es not_active Expired - Lifetime
- 1999-12-01 KR KR1020017007176A patent/KR20010080729A/ko not_active Application Discontinuation
- 1999-12-01 MX MXPA01005861A patent/MXPA01005861A/es active IP Right Grant
- 1999-12-01 HU HU0104624A patent/HUP0104624A3/hu unknown
- 1999-12-01 AU AU17793/00A patent/AU766810B2/en not_active Ceased
- 1999-12-01 BR BR9916006-4A patent/BR9916006A/pt not_active IP Right Cessation
- 1999-12-01 AT AT99961041T patent/ATE218370T1/de not_active IP Right Cessation
- 1999-12-01 DE DE59901681T patent/DE59901681D1/de not_active Expired - Fee Related
- 1999-12-01 JP JP2000586366A patent/JP2002531525A/ja not_active Withdrawn
- 1999-12-01 CZ CZ20012029A patent/CZ20012029A3/cs unknown
- 1999-12-01 EE EEP200100305A patent/EE200100305A/xx unknown
- 1999-12-01 PL PL99349336A patent/PL349336A1/xx not_active Application Discontinuation
- 1999-12-01 IL IL14358699A patent/IL143586A0/xx unknown
- 1999-12-01 SK SK788-2001A patent/SK284842B6/sk unknown
- 1999-12-01 SI SI9930063T patent/SI1137438T1/xx unknown
- 1999-12-01 YU YU39901A patent/YU39901A/sh unknown
- 1999-12-01 CN CNB998142433A patent/CN1189214C/zh not_active Expired - Fee Related
- 1999-12-07 AR ARP990106239A patent/AR021577A1/es not_active Application Discontinuation
-
2001
- 2001-05-30 BG BG105548A patent/BG105548A/xx unknown
- 2001-06-01 NO NO20012719A patent/NO20012719D0/no not_active Application Discontinuation
- 2001-06-07 HR HR20010429A patent/HRP20010429A2/hr not_active Application Discontinuation
- 2001-06-13 ZA ZA200104815A patent/ZA200104815B/en unknown
-
2002
- 2002-05-02 HK HK02103282.9A patent/HK1041598B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20053660B (en) | Novel Tyrosine Kinase Inhibitors | |
| BG106585A (en) | Kinase inhibitors as therapeutic agents | |
| CA2200707A1 (fr) | Nouveaux inhibiteurs de la prostaglandine-synthase | |
| EA200400006A1 (ru) | Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов | |
| CA2400447A1 (fr) | Inhibiteurs de kinases | |
| ES2194567A1 (es) | Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas | |
| BR0116468A (pt) | Compostos de pirrolina substituìda por indazolila como inibidores de cinase | |
| BR9910296A (pt) | Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado | |
| BG101422A (en) | Benzoxazole derivatives as bronchodilating compounds | |
| EP1379251A4 (fr) | Inhibiteurs d'activite de l'enzyme akt | |
| BR9807674A (pt) | Inibidores bicìclicos da proteìna farnesil transferase | |
| HK1078850A1 (en) | Novel alkoxypyridine-derivatives | |
| EP1163208A4 (fr) | Inhibiteurs de caspase et leurs utiilsations | |
| MX173955B (es) | Composicion desodorante que contiene inhibidores de la enzima beta-liasa de aminoacidos | |
| BG105548A (en) | Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors | |
| CA2266759A1 (fr) | Derives 3-mercaptoacetylamino-1,5-substitue-2-oxo-azepane, utilises comme inhibiteurs de metalloproteinase matrice | |
| EA200100297A1 (ru) | Моногидрат гидробромида элетриптана | |
| EA200100140A1 (ru) | Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами | |
| EA200100141A1 (ru) | Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами | |
| DE59203777D1 (en) | Aminomethylencyanessigsäureester und -amide. | |
| GB9806409D0 (en) | Processes for preparing intermediates | |
| DK1019347T3 (da) | Fremgangsmåde til syntesen af taxaner | |
| ATE265854T1 (de) | Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs | |
| EP1057829A4 (fr) | Dérivés de la pyrimidine condensés et compositions pharmaceutiques les contenant | |
| DE50006244D1 (en) | Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine |